Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2013


Technology Transfer

26 Jun 2013 - 28 Jun 2013 - London, UK



Bookmark and Share


This three-day interactive workshop is intended to provide an overview of the challenges that must be overcome in transferring manufacturing technology and to highlight some proven techniques for overcoming those challenges.


The focus of the course is on small-molecules and their formulations rather than biological products, although many of the issues faced and techniques discussed will be equally applicable.


Some of the benefits to be derived from this workshop include:

  • An appreciation of where TT fits in the life cycle of a pharmaceutical product.
  • An appreciation of the importance of planning and project management in TT
  • An overview of the potential complexity of technology and product transfer.
  • An outline of proven best practice in technology transfer.
  • An opportunity to discuss current issues and challenges in technology transfer with peers and with an expert faculty.
  • A consideration of 'where next' as we move from traditionally-developed products to a world where products are developed using QbD techniques and controlled by PAT.

Who Should Attend?

Pharmaceutical technologists, Quality Assurance staff, Regulatory staff, Engineering staff, Project Managers and anybody else involved in the transfer of products or technology from one location to another.

Course Programme

Day 1

Why Transfer Technology?

Pharmaceutical Product Life Cycle

  • Development
  • Innovative
  • Mature
  • Generic

Product Transfers and Technology Transfers

  • IP
  • Technology
  • Techniques
  • Regulatory Considerations

Registration Procedures

  • Europe
  • Non-European

Variation Procedures

  • Types of Variations
  • Advantages and Disadvantages

Day 2

Technical Challenges

  • Manufacturing processes
  • Validation
  • Stability
  • Packaging processes

Logistical Challenges

  • Label Changes * Text * Physical
  • Timing * Project Plan * Phase in/out

Day 3

Technical Challenges (2)

Impact of new technology

  •  Quality by Design
  •  Process Analytical Technology

Human Challenges

  • Push versus Pull
  • Team membership and team roles
  • Cross-Cultural Issues
  • Progress Reporting and breaking bad news


Further information
Scientific News
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!